Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform ‘IDC224’… Driving Innovation in Subcutaneous (SC) Formulations
SEOUL, South Korea, April 22, 2026 /PRNewswire/ — Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced…
